Anti-Diabetes Drugs - EMEA

EMEA

Revenue in the Anti-Diabetes Drugs market is projected to reach US$15.16bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.15%, resulting in a market volume of US$18.53bn by 2028.
In global comparison, most revenue will be generated in the United States (US$37,840.00m in 2024).

Key regions: India, Australia, Italy, Europe, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

The Anti-Diabetes Drugs market is experiencing steady growth. This development is driven by the number of patients, which is projected to increase continuously over the next years. The majority of cases are type 2 diabetes, which is associated with obesity, and the number of obese people worldwide is projected to increase by a few percent every year. Additionally, the market is driven by an increasing awareness of health issues and by improving access to healthcare in emerging countries.

At the beginning of the COVID-19 pandemic, there were stocking effects brought about by patients fearing a shortage of medications. This led to an increase in sales of some products, which, however, is not reflected in the annual revenue numbers as it was counterbalanced later in 2020. Instead, growth declined by some percentage points because fewer patients decided to seek treatment.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.